HealthLynked Corp NAPLES, Fla., March 19, 2024 (GLOBE

New Post Public Reply Private Reply Replies (0) Message Board
LocWolf
258
HealthLynked Corp

NAPLES, Fla., March 19, 2024 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp (OTCQB: HLYK), a leader in healthcare technology innovation, is excited to announce Chris Hall as the new Chief Technology Officer (CTO). Chris brings a wealth of experience in technology and product development, marked by his leadership in launching over 100 products and managing diverse, global teams. His strategic foresight and technological prowess have been successfully demonstrated across various roles, making significant impacts in product development and commercialization.

Before his appointment at HealthLynked, Chris worked at Battelle as a Sr. Product Portfolio Manager and at HF Scientific as the Manager of New Product Development after spending nearly two decades working for Siemens and their affiliates developing cutting edge technologies for the global market. His leadership in these roles led to substantial sales growth and the adoption of agile methodologies, enhancing product development processes and operational efficiency. His demonstrated success in these endeavors should have a positive impact on HealthLynked's network growth strategy in the years to come.

Notably, Chris has been responsible for over a dozen patents across multiple technologies, showcasing his inventive spirit and contribution to technological advancement in various sectors.

Chris holds an MBA from Western Governor's University and a B.Sc. in Chemical Engineering from Colorado State University. He is also a certified Project Management Professional (PMP), with expertise in regulatory compliance, budgeting, financial analysis, and agile project management.

In his role at HealthLynked, Chris will oversee the company's technology strategy, focusing on the development and coordination of innovative healthcare solutions. He will manage and synchronize the development processes between HealthLynked's USA and Indian development teams, crucial for the seamless execution of crucial projects like ARI, HealthLynked's personalized AI healthcare guide. ARI aims to revolutionize patient care by offering tailored health guidance that will be a major factor in distinguishing HealthLynked's app in the marketplace.

Dr. Michael Dent, CEO of HealthLynked, expressed his enthusiasm about Chris's appointment: "Chris joining us marks a transformative step forward. His leadership in managing our global teams, especially in the development of innovative projects like ARI, is invaluable. His track record of securing patents and pushing technological boundaries aligns perfectly with our mission."

Chris Hall commented on his new role: "I'm truly impressed by HealthLynked's vision to enhance healthcare globally, focusing on efficiency and patient-centered care. It's an honor to be part of a team that not only values innovation but actively works to make a real difference. I'm eager to leverage my experience and the patents I've been involved with to contribute to our mission of transforming healthcare through advanced technology."

Chris Hall's appointment reflects HealthLynked's commitment to excellence and innovation in healthcare technology. The company looks forward to the advancements and improvements Chris will bring, aiming to enhance healthcare delivery and patient outcomes worldwide.

About HealthLynked

HealthLynked Corp. is dedicated to enhancing healthcare by facilitating the efficient exchange of medical information between patients and providers. Our cloud based HealthLynked Network empowers members to actively manage their healthcare, providing a centralized and secure location for their medical data, including medications, allergies, past surgeries, and personal health records.

Healthcare providers in our network benefit from improved patient care and key insights into their practice operations. Additionally, our preferred providers can leverage HealthLynked's marketing tools to engage both patients, ensuring better patient compliance and optimized scheduling. To avail these services, providers need to claim their profiles and complete the necessary steps to become an in-network provider.

For more about HealthLynked Corp., please visit www.healthlynked.com. Stay connected with HealthLynked on Facebook, Twitter, Instagram, and LinkedIn.

Forward-Looking Statements & Risk Factors

This press release contains forward-looking statements that are not based on historical facts. These statements, as defined by the Private Securities Litigation Reform Act of 1995, may differ from actual results, performance, or achievements. Forward-looking statements involve inherent risks and uncertainties. We advise against placing undue reliance on these statements, which are current only as of the date of this press release.

We are not obligated to publicly update any forward-looking statements unless required by law. Any updates should not be interpreted as an indication of additional updates on the same or other topics. For a detailed understanding of the risks and uncertainties related to our operations, please refer to the "Risk Factors" in our latest Annual Report on Form 10-K and other filings with the U.S. Securities and Exchange Commission, available at www.sec.gov.

HLYK Contact:

Mike Paisan
Director of Investor Relations
IR@healthlynked.com
+1 (800)-928-7144, ext. 123

Wire Service Contact:

IBN
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.comhttps://finance.yahoo.com/news/healthlynked-corp-announces-chris-hall-120000908.html

Healthlynked Corp (HLYK) Stock Research Links

HLYK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 0

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Cat Holdings Faces Class Action Lawsuit from Investors

Updated Category News Views 209

Overview of the Class Action Against Red Cat Holdings Pomerantz LLP has announced that a class action lawsuit has been initiated against Red Cat Holdings, Inc. (RCAT) and certain officers due to allegations of misconduct. The legal action is filed in the United States District Court for the District of New Jersey. This lawsuit represents a class of individuals or entities...

Continue Reading
IPVanish: The Ultimate Solution for Cloud Storage Security

Updated Category News Views 129

IPVanish: Leading the Charge in Cloud Security As more individuals and businesses migrate to the cloud, the urgency for secure storage solutions has skyrocketed. IPVanish has stepped up to become a standout player in this landscape, recognized for its outstanding cloud access tools and strong privacy measures. Transformation into a Comprehensive Security Platform...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 11

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading
Investors Anticipate Earnings from Booz Allen Hamilton Soon

Updated Category News Views 134

Market Expectations for Booz Allen Hamilton's Earnings Booz Allen Hamilton (NYSE: BAH) is set to unveil its quarterly earnings soon, and it's important for investors to be well-prepared. Analysts anticipate an earnings per share (EPS) of $1.51, a key figure to watch as it could impact stock sentiment significantly. Performance Insights and Analyst Predictions The hope...

Continue Reading
USD/JPY Holds Steady Amid Economic Shifts and Data Releases

Updated Category News Views 124

USD/JPY Stabilizes After Inflation Adjustments The USD/JPY currency pair has recently stabilized after a brief drop below the key level of 141.77. This dip happened just before the US Consumer Price Index (CPI) was announced, revealing an inflation rate of 2.5%. Following this data release, the currency pair started to rebound, thanks in part to a slight increase in US...

Continue Reading